Cadastro completo das bolsas americanas, histórico de preços, demonstrações financeiras, indicadores, rentabilidade, crescimento, endividamento, qualidade, mercado e dividendos.
Ações ordinárias, common stocks e ADRs/ADSs ativos; ETFs, units, warrants, direitos e preferenciais ficam fora desta aba.
Explorar REITs americanosações no escopo
ligadas à SEC
com preços
com fundamentos
última cotação
Identidade regulatória, demonstrações anuais e trimestrais e dividendos declarados vêm do EDGAR/XBRL.
Nasdaq Trader cobre Nasdaq, NYSE, NYSE American, NYSE Arca, Cboe e IEX.
A janela pública da Nasdaq tem prioridade; Yahoo Finance completa o período anterior sem ser rotulado como oficial.
Destaques do mercado
Listas objetivas calculadas sobre todo o universo de ações dos EUA, com preços de mercado e fundamentos SEC.
Screener dos EUA
| Ação | Bolsa | Preço | Valor de mercado | P/L |
|---|
NVDAUS$ 19,44 bi
AMDUS$ 17,84 bi“Mais populares” usa volume financeiro do último pregão como proxy de interesse; não utiliza histórico individual de navegação. Os rankings consideram ações com valor de mercado a partir de US$ 1 bilhão e volume financeiro diário de ao menos US$ 1 milhão.
| P/VP |
|---|
| ROE |
|---|
| Dividend Yield |
|---|
| Referência |
|---|
MBIOMustang Bio, Inc. - Common Stock | NASDAQ | US$ 0,51 | US$ 2,49 mi | — | 0,26x | -20,16% | — | Preço 11/09/2026 SEC 31/12/2025 |
UPCUniverse Pharmaceuticals Inc - Class A Ordinary Shares | NASDAQ | US$ 4,36 | US$ 2,46 mi | — | 0,00x | -6,54% | — | Preço 11/09/2026 SEC 30/09/2025 |
SXTCChina SXT Pharmaceuticals, Inc. - Class A Ordinary Shares | NASDAQ | US$ 2,56 | US$ 2,45 mi | — | 0,08x | -20,89% | — | Preço 11/09/2026 SEC 31/03/2026 |
AEONAEON Biopharma, Inc. Class A Common Stock | NYSE American | US$ 0,24 | US$ 2,41 mi | — | -0,04x | 71,28% | — | Preço 18/09/2026 SEC 31/12/2025 |
CNSPCNS Pharmaceuticals, Inc. - Common Stock | NASDAQ | US$ 5,11 | US$ 2,27 mi | — | 0,50x | -350,48% | — | Preço 18/09/2026 SEC 31/12/2025 |
CVKDCadrenal Therapeutics, Inc. - Common Stock | NASDAQ | US$ 1,05 | US$ 2,09 mi | — | 0,76x | -483,34% | 1.571,43% | Preço 15/09/2026 SEC 31/12/2025 |
ACXPAcurx Pharmaceuticals, Inc. - Common Stock | NASDAQ | US$ 1,39 | US$ 2,08 mi | — | 0,40x | -151,21% | — | Preço 18/09/2026 SEC 31/12/2025 |
NUVBNuvation Bio Inc. Class A Common Stock | NYSE | US$ 6,07 | US$ 2,07 mi | — | 0,01x | -66,93% | — | Preço 11/09/2026 SEC 31/12/2025 |
NXTSNexentis Technologies Inc. - Common Stock | NASDAQ | US$ 1,58 | US$ 2,04 mi | — | 0,13x | -25,45% | — | Preço 14/09/2026 SEC 31/12/2025 |
SNGXSoligenix, Inc. - Common Stock | NASDAQ | US$ 0,36 | US$ 1,89 mi | — | 0,36x | -209,37% | — | Preço 11/09/2026 SEC 31/12/2025 |
BCTXBriaCell Therapeutics Corp. - Common Shares | NASDAQ | US$ 4,21 | US$ 1,78 mi | — | 0,10x | -151,79% | — | Preço 18/09/2026 SEC 31/07/2025 |
ENSCEnsysce Biosciences, Inc. - Common Stock | NASDAQ | US$ 0,49 | US$ 1,25 mi | — | 0,43x | — | — | Preço 11/09/2026 SEC 31/12/2025 |
RNAZTransCode Therapeutics, Inc. - Common Stock | NASDAQ | US$ 1,67 | US$ 1,15 mi | — | 0,11x | -335,36% | — | Preço 14/09/2026 SEC 31/12/2025 |
DRMADermata Therapeutics, Inc. - Common Stock | NASDAQ | US$ 1,13 | US$ 1,05 mi | — | 0,17x | -121,45% | — | Preço 15/09/2026 SEC 31/12/2025 |
OGENOragenics Inc. Common Stock | NYSE American | US$ 0,49 | US$ 1,05 mi | — | 0,13x | -118,85% | — | Preço 14/09/2026 SEC 31/12/2025 |
MTNBMatinas Biopharma Holdings, Inc. Common Stock | NYSE American | US$ 0,19 | US$ 1,01 mi | — | 0,21x | -214,18% | — | Preço 11/09/2026 SEC 31/12/2025 |
AZTRAzitra Inc Common Stock | NYSE American | US$ 0,17 | US$ 848,00 mil | — | 0,22x | -288,21% | — | Preço 18/09/2026 SEC 31/12/2025 |
JAGXJaguar Health, Inc. - Common Stock | NASDAQ | US$ 0,31 | US$ 732,37 mil | — | -0,04x | 286,68% | — | Preço 11/09/2026 SEC 31/12/2025 |
PRFXPRF Technologies Ltd. - Ordinary Shares | NASDAQ | US$ 0,86 | US$ 714,41 mil | — | 0,08x | -54,06% | — | Preço 11/09/2026 SEC 31/12/2025 |
ONCOOnconetix, Inc. - Common Stock | NASDAQ | US$ 0,76 | US$ 709,27 mil | — | 0,04x | -89,01% | — | Preço 11/09/2026 SEC 31/12/2025 |
CRMDCorMedix Inc. - Common Stock | NASDAQ | US$ 7,76 | US$ 623,19 mil | 3,80x | 0,00x | 40,23% | — | Preço 15/09/2026 SEC 31/12/2025 |
REVBRevelation Biosciences, Inc. - Common Stock | NASDAQ | US$ 0,97 | US$ 604,40 mil | — | 0,07x | -100,59% | — | Preço 14/09/2026 SEC 31/12/2025 |
SXTP60 Degrees Pharmaceuticals, Inc. - Common Stock | NASDAQ | US$ 0,90 | US$ 603,19 mil | — | 0,18x | -217,94% | — | Preço 11/09/2026 SEC 31/12/2025 |
APVOAptevo Therapeutics Inc. - Common Stock | NASDAQ | US$ 1,84 | US$ 580,58 mil | — | 0,03x | -149,40% | — | Preço 18/09/2026 SEC 31/12/2025 |
ENVBEnveric Biosciences, Inc. - Common Stock | NASDAQ | US$ 1,42 | US$ 475,30 mil | — | 0,11x | -209,98% | — | Preço 11/09/2026 SEC 31/12/2025 |
ENTAEnanta Pharmaceuticals, Inc. - Common Stock | NASDAQ | US$ 12,96 | US$ 276,51 mil | — | 0,00x | -126,53% | — | Preço 11/09/2026 SEC 30/09/2025 |
DCOYDecoy Therapeutics Inc. - Common Stock | NASDAQ | US$ 2,71 | US$ 262,78 mil | — | 0,04x | -212,58% | — | Preço 15/09/2026 SEC 31/12/2025 |
FULCFulcrum Therapeutics, Inc. - Common Stock | NASDAQ | US$ 3,80 | US$ 240,75 mil | — | 0,00x | -21,46% | — | Preço 11/09/2026 SEC 31/12/2025 |
GRIGRI Bio, Inc. - Common Stock | NASDAQ | US$ 1,90 | US$ 186,51 mil | — | 0,03x | -199,00% | — | Preço 11/09/2026 SEC 31/12/2025 |
ANIXAnixa Biosciences, Inc. - Common Stock | NASDAQ | US$ 2,77 | US$ 89,90 mil | — | 0,01x | -78,33% | — | Preço 18/09/2026 SEC 31/10/2025 |
RANIRani Therapeutics Holdings, Inc. - Class A Common Stock | NASDAQ | US$ 0,85 | US$ 56,02 mil | — | 0,00x | -71,48% | — | Preço 14/09/2026 SEC 31/12/2025 |
KPTIKaryopharm Therapeutics Inc. - Common Stock | NASDAQ | US$ 1,61 | US$ 17,61 mil | — | -0,00x | 66,92% | — | Preço 11/09/2026 SEC 31/12/2025 |
CDTCDT Equity Inc. - Common Stock | NASDAQ | US$ 0,17 | US$ 5,79 mil | — | -0,00x | 547,06% | — | Preço 18/09/2026 SEC 31/12/2025 |
AAPGAscentage Pharma Group International - American Depository Shares | NASDAQ | US$ 15,06 | — | — | — | -147,97% | — | Preço 18/09/2026 SEC 31/12/2024 |
AKTSAktis Oncology, Inc. - Common stock | NASDAQ | US$ 21,88 | — | — | — | — | — | Preço 18/09/2026 SEC — |
ALLRAllarity Therapeutics, Inc. - Common stock | NASDAQ | US$ 1,21 | — | — | — | -114,28% | — | Preço 18/09/2026 SEC 31/12/2025 |
ANLAdlai Nortye Group Ltd. - American Depositary Shares | NASDAQ | US$ 15,74 | — | — | — | -203,53% | — | Preço 18/09/2026 SEC 31/12/2024 |
APLMApollomics Inc. - Class A Ordinary Shares | NASDAQ | US$ 23,42 | — | — | — | -1.107,28% | — | Preço 18/09/2026 SEC 31/12/2024 |
APMDApnimed, Inc. - Common Stock | NASDAQ | US$ 29,00 | — | — | — | — | — | Preço 18/09/2026 SEC — |
AVLNAvalyn Pharma Inc. - common stock | NASDAQ | US$ 31,52 | — | — | — | — | — | Preço 18/09/2026 SEC — |
AYTUAytu BioPharma, Inc. - Common Stock | NASDAQ | US$ 2,12 | — | — | — | -71,51% | — | Preço 18/09/2026 SEC 30/06/2025 |
AZNAstraZeneca PLC Ordinary Shares | NYSE | US$ 166,08 | — | 25,39x | — | 21,00% | — | Preço 18/09/2026 SEC 31/12/2025 |
BLRXBioLineRx Ltd. - American Depositary Shares | NASDAQ | US$ 2,49 | — | — | — | -8,68% | — | Preço 18/09/2026 SEC 31/12/2025 |
BLSMBlossomHill Therapeutics, Inc. - Common Stock | NASDAQ | US$ 25,74 | — | — | — | — | — | Preço 18/09/2026 SEC — |
BRVEBraveheart Bio, Inc. - Common Stock | NASDAQ | US$ 29,20 | — | — | — | — | — | Preço 18/09/2026 SEC — |
BYSIBeyondSpring, Inc. - Ordinary Shares | NASDAQ | US$ 0,75 | — | — | — | 4,19% | — | Preço 18/09/2026 SEC 31/12/2025 |
CBIOCrescent Biopharma, Inc. - Common Stock | NASDAQ | US$ 16,89 | — | — | — | -75,83% | — | Preço 18/09/2026 SEC 31/12/2025 |
CLNNClene Inc. - Common Stock | NASDAQ | US$ 4,35 | — | — | — | 148,78% | — | Preço 18/09/2026 SEC 31/12/2025 |
CMNDClearmind Medicine Inc. - Common Shares | NASDAQ | US$ 0,80 | — | — | — | -323,41% | — | Preço 18/09/2026 SEC 31/10/2025 |
CPHIChina Pharma Holdings, Inc. Common Stock | NYSE American | US$ 0,71 | — | — | — | -14,02% | — | Preço 18/09/2026 SEC 31/12/2025 |
CRVOCervoMed Inc. - Common Stock | NASDAQ | US$ 2,45 | — | — | — | -147,98% | — | Preço 15/09/2026 SEC 31/12/2025 |
DMACDiaMedica Therapeutics Inc. - Common Stock | NASDAQ | US$ 6,53 | — | — | — | -58,39% | — | Preço 15/09/2026 SEC 31/12/2025 |
DYNDyne Therapeutics, Inc. - Common Stock | NASDAQ | US$ 18,21 | — | — | — | -45,90% | — | Preço 11/09/2026 SEC 31/12/2025 |
EDSAEdesa Biotech, Inc. - Common Shares | NASDAQ | US$ 4,23 | — | — | — | -57,71% | — | Preço 11/09/2026 SEC 30/09/2025 |
ELABPMGC Holdings Inc. - Common Stock | NASDAQ | US$ 4,52 | — | — | — | -98,86% | — | Preço 11/09/2026 SEC 31/12/2025 |
ETONEton Pharmaceuticals, Inc. - Common Stock | NASDAQ | US$ 57,08 | — | — | — | -17,59% | — | Preço 11/09/2026 SEC 31/12/2025 |
GELSGelteq Limited - Ordinary Shares | NASDAQ | US$ 0,70 | — | — | — | -42,05% | — | Preço 11/09/2026 SEC 30/06/2025 |
GENBGenerate Biomedicines, Inc. - Common Stock | NASDAQ | US$ 15,72 | — | — | — | — | — | Preço 11/09/2026 SEC — |
GMABGenmab A/S - American Depositary Shares | NASDAQ | US$ 32,47 | — | 2,11x | — | 16,47% | — | Preço 11/09/2026 SEC 31/12/2025 |
GNPXGenprex, Inc. - Common Stock | NASDAQ | US$ 3,35 | — | — | — | -203,83% | — | Preço 11/09/2026 SEC 31/12/2025 |
GOVXGeoVax Labs, Inc. - Common Stock | NASDAQ | US$ 0,46 | — | — | — | -561,15% | — | Preço 11/09/2026 SEC 31/12/2025 |
GRFSGrifols, S.A. - American Depositary Shares | NASDAQ | US$ 7,55 | — | 32,83x | — | 2,47% | — | Preço 11/09/2026 SEC 31/12/2024 |
IBOImpact BioMedical, Inc. Common Stock | NYSE American | US$ 0,46 | — | — | — | -76,10% | — | Preço 11/09/2026 SEC 31/12/2025 |
KARDKardigan, Inc. - Common Stock | NASDAQ | US$ 18,52 | — | — | — | — | — | Preço 11/09/2026 SEC — |
KLRAKailera Therapeutics, Inc. - Common stock | NASDAQ | US$ 13,94 | — | — | — | — | — | Preço 11/09/2026 SEC — |
LABTLakewood-Amedex Biotherapeutics Inc. - Common Stock | NASDAQ | US$ 2,21 | — | — | — | — | — | Preço 14/09/2026 SEC — |
LRMRLarimar Therapeutics, Inc. - Common Stock | NASDAQ | US$ 3,89 | — | — | — | -212,17% | — | Preço 14/09/2026 SEC 31/12/2025 |
LTGOLatigo Biotherapeutics, Inc. - Common Stock | NASDAQ | US$ 23,31 | — | — | — | — | — | Preço 14/09/2026 SEC — |
MBRXMoleculin Biotech, Inc. - Common Stock | NASDAQ | US$ 0,72 | — | — | — | -223,64% | — | Preço 11/09/2026 SEC 31/12/2025 |
MIRAMIRA Pharmaceuticals, Inc. - Common Stock | NASDAQ | US$ 0,77 | — | — | — | -100,49% | — | Preço 11/09/2026 SEC 31/12/2025 |
MISTMilestone Pharmaceuticals Inc. - Common Shares | NASDAQ | US$ 0,98 | — | — | — | -150,97% | — | Preço 11/09/2026 SEC 31/12/2025 |
MNPRMonopar Therapeutics Inc. - Common Stock | NASDAQ | US$ 110,26 | — | — | — | -9,95% | — | Preço 11/09/2026 SEC 31/12/2025 |
NRXPNRX Pharmaceuticals, Inc. - Common Stock | NASDAQ | US$ 3,40 | — | — | — | 179,59% | — | Preço 11/09/2026 SEC 31/12/2025 |
NVONovo Nordisk A/S Common Stock | NYSE | US$ 43,07 | — | 1,87x | — | 52,79% | — | Preço 11/09/2026 SEC 31/12/2025 |
OBXObsidian Therapeutics, Inc. - Common Stock | NASDAQ | US$ 18,01 | — | — | — | — | — | Preço 14/09/2026 SEC — |
OCSOculis Holding AG - Ordinary shares | NASDAQ | US$ 10,66 | — | — | — | -50,47% | — | Preço 14/09/2026 SEC 31/12/2025 |
OMEROmeros Corporation - Common Stock | NASDAQ | US$ 18,28 | — | — | — | 2,76% | — | Preço 11/09/2026 SEC 31/12/2025 |
OPTHOptimi Health Corp. - Common Shares | NASDAQ | US$ 4,42 | — | — | — | — | — | Preço 11/09/2026 SEC — |
ORKAOruka Therapeutics, Inc. - Common Stock | NASDAQ | US$ 92,38 | — | — | — | -22,34% | — | Preço 11/09/2026 SEC 31/12/2025 |
OVIDOvid Therapeutics Inc. - Common Stock | NASDAQ | US$ 2,69 | — | — | — | -13,33% | — | Preço 11/09/2026 SEC 31/12/2025 |
PBLSParabilis Medicines, Inc. - Common Stock | NASDAQ | US$ 36,88 | — | — | — | — | — | Preço 11/09/2026 SEC — |
PHIOPhio Pharmaceuticals Corp. - Common Stock | NASDAQ | US$ 1,03 | — | — | — | -43,17% | — | Preço 11/09/2026 SEC 31/12/2025 |
QNRXQuoin Pharmaceuticals, Ltd. - American Depositary Shares | NASDAQ | US$ 6,78 | — | — | — | -120,46% | — | Preço 14/09/2026 SEC 31/12/2025 |
QNTMQuantum Biopharma Ltd. - Class B Subordinate Voting Shares | NASDAQ | US$ 3,50 | — | — | — | — | — | Preço 14/09/2026 SEC 31/12/2025 |
RACCResearch Alliance Corporation III - Class A Ordinary Shares | NASDAQ | US$ 11,35 | — | — | — | — | — | Preço 14/09/2026 SEC — |
RNAAtrium Therapeutics, Inc. - Common Stock | NASDAQ | US$ 10,37 | — | — | — | — | — | Preço 14/09/2026 SEC — |
SBFMSunshine Biopharma Inc. - Common stock | NASDAQ | US$ 1,06 | — | — | — | -25,94% | — | Preço 11/09/2026 SEC 31/12/2025 |
SPTXSeaport Therapeutics, Inc. - Common Stock | NASDAQ | US$ 23,34 | — | — | — | — | — | Preço 11/09/2026 SEC — |
SYRESpyre Therapeutics, Inc. - Common Stock | NASDAQ | US$ 90,60 | — | — | — | -21,70% | — | Preço 11/09/2026 SEC 31/12/2025 |
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | NYSE | US$ 18,26 | — | 0,27x | — | 1,56% | — | Preço 11/09/2026 SEC 31/03/2025 |
TLPHTalphera, Inc. - Common Stock | NASDAQ | US$ 1,24 | — | — | — | -83,89% | — | Preço 11/09/2026 SEC 31/12/2025 |
TRAXFirst Tracks Biotherapeutics, Inc. - Ordinary Shares | NASDAQ | US$ 36,44 | — | — | — | — | — | Preço 11/09/2026 SEC — |
URGNUroGen Pharma Ltd. - Ordinary Shares | NASDAQ | US$ 42,31 | — | — | — | 145,53% | — | Preço 11/09/2026 SEC 31/12/2025 |
VBIOValion Bio, Inc. - Common stock | NASDAQ | US$ 2,26 | — | — | — | -52,85% | — | Preço 11/09/2026 SEC 31/12/2025 |
VCREVicore Pharma Holding AB - American Depositary Shares | NASDAQ | US$ 10,78 | — | — | — | — | — | Preço 11/09/2026 SEC — |
VERUVeru Inc. - Common Stock | NASDAQ | US$ 2,44 | — | — | — | -123,97% | — | Preço 11/09/2026 SEC 30/09/2025 |
VOGXVogenx Inc - Common Stock | NASDAQ | US$ 32,71 | — | — | — | — | — | Preço 11/09/2026 SEC — |
VRDNViridian Therapeutics, Inc. - Common Stock | NASDAQ | US$ 21,24 | — | — | — | -47,44% | — | Preço 11/09/2026 SEC 31/12/2025 |
VRXAVeraxa Biotech AG - Ordinary Shares | NASDAQ | US$ 1,65 | — | — | — | — | — | Preço 11/09/2026 SEC — |
VTRSViatris Inc. - Common Stock | NASDAQ | US$ 16,51 | — | — | — | — | 2,91% | Preço 11/09/2026 SEC 31/12/2025 |